Enquyst Technologies Inc

Enquyst Technologies is on a quest to engineer next-generation biomanufacturing technology solutions to give the growing diversity of life changing and curative treatments a viable path to the clinic with affordable costs. The unprecedentedly high purity resulting from Enquyst’s patented, core IPP technology is expected to deliver a scalable solution for the purification of AAV and lentiviral vector-based gene therapies, enabling development and rapid growth of these markets. Enquyst’s core IPP technology and accompanying novel equipment modules offer the flexibility to purify peptides, therapeutic proteins, monoclonal antibodies, bispecific antibodies, oligonucleotides (e.g. mRNA), and viral vectors for gene therapy from a single, small footprint and scalable production line, capable of serving development and commercial production activities.